The myth of the biotech revolution: An assessment of technological, clinical and organisational change
- 1 May 2007
- journal article
- Published by Elsevier in Research Policy
- Vol. 36 (4) , 566-589
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Next-generation monoclonals less profitable than trailblazers?Nature Biotechnology, 2005
- Molecular genetics: the Emperor's clothes of drug discovery?Drug Discovery Today, 2004
- Prospects for productivityNature Reviews Drug Discovery, 2004
- Key factors in the rising cost of new drug discovery and developmentNature Reviews Drug Discovery, 2004
- Biotechnology: identifying advances from the hypeNature Reviews Drug Discovery, 2004
- Value of novelty?Nature Reviews Drug Discovery, 2002
- Pharmacogenetics and the future of medical practiceBritish Journal of Clinical Pharmacology, 2002
- European exploitation of biotechnology—do government policies help?Nature Biotechnology, 2000
- Getting the right drug into the right patientNature Biotechnology, 1997
- Superfamily Structure and Biotech Drug DevelopmentNature Biotechnology, 1992